SESAME LIMITED

Financial Health Assessment: SESAME LIMITED

1. Financial Health Score: B (Stable / Structurally Sound)

Explanation: Sesame Limited earns a solid 'B' due to its excellent compliance health and the robust backing of its parent company. However, the lack of visible standalone financial reserves (indicated by a mere £88 in share capital) prevents a higher score. The company appears to be a financially dependent entity within a larger corporate body—healthy so long as the parent remains healthy, but lacking independent financial immunity.

2. Key Vital Signs

• Pulse (Corporate Lifespan): Incorporated in 1993, this is a mature entity with a 30-year track record. In medical terms, the patient has a strong, steady pulse and a long history of survival in the corporate ecosystem.
• Blood Pressure (Compliance & Filing): Filings are completely up to date, with the next accounts not due until September 2027. This indicates excellent regulatory blood pressure—no signs of administrative stress or blockages.
• White Blood Cell Count (Governance & Leadership): The company exhibits a very high white blood cell count with 13 active officers (including 12 directors and a corporate secretary). This heavy administrative presence suggests the entity is heavily governed, acting as a critical node within a larger corporate anatomy rather than a lean, independent operator.
• Corporate DNA (Ownership & Control): Sesame Bankhall Group Limited owns more than 75% of the shares, holds more than 75% of the voting rights, and has the right to appoint/remove directors. The DNA of this company is entirely entwined with its parent; it has no independent genetic traits.
• Blood Sugar (Capital Reserves): £88 in share capital. This is a remarkably low figure, serving as a key symptom. It suggests the company either operates with minimal standalone equity, relies entirely on intercompany funding (financial transfusions) from its parent, or acts as a holding/administrative vehicle.

3. Diagnosis

Based on the available structural data, Sesame Limited presents as an asymptomatic, dependent subsidiary.

Because the detailed financial blood work (balance sheet, P&L reserves) is not provided in this dataset, we must diagnose based on structural symptoms. The patient is not fighting any immediate infections (no overdue filings, no signs of liquidation or administration). However, the £88 share capital reveals that this entity is highly anemic in terms of independent equity. It is not standing on its own two feet financially; rather, it is on life support from Sesame Bankhall Group Limited.

The company functions as an administrative artery—previously known as Kestrel Financial Management Limited before a corporate "transplant" in 2003—within the broader Aviva/Sesame Bankhall network. Its purpose is to serve as a mortgage, protection, and general insurance network hub. The extensive board of directors is typical for a network hub that requires oversight from various corners of a larger financial conglomerate. The patient is healthy, but its health is entirely borrowed from its parent.

4. Recommendations

To improve its financial wellness and ensure long-term viability, the following actions are recommended:

• Review Intercompany Transfusions: Given the £88 share capital, the business almost certainly relies on intercompany loans or parent equity injections to fund its operations. Management should ensure these funding lines are formally documented and reviewed annually to prevent sudden financial starvation if the parent company's health falters.
• Maintain Compliance Hygiene: The current regulatory vitals are excellent. Continue prioritizing timely filings with Companies House to avoid unnecessary penalties, which can act as unnecessary stressors to a corporate immune system.
• Monitor Parent Health: Because Sesame Limited's financial heartbeat is directly synced with Sesame Bankhall Group Limited, the directors must keep a close eye on the parent company's financial statements. Any symptoms of distress at the group level will immediately cascade down to this entity.
• Evaluate Capital Structure: While £88 in share capital is legally permissible for a subsidiary supported by a parent, directors should periodically evaluate whether a capitalization event (increasing share capital) is necessary to better reflect the true scale of the business and provide a buffer against operational shocks.